AAA

180 Life Sciences Corp.

No trades
See on Supercharts
Market capitalization
‪1.55 M‬USD
−64.34USD
‪−19.94 M‬USD
‪517.55 K‬
Beta (1Y)
1.87

About 180 Life Sciences Corp.

CEO
Jim N. Woody
Headquarters
Palo Alto
Employees (FY)
4
Founded
2016
FIGI
BBG00H1CP0B4
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ATNF is 1.80 USD — it has decreased by 1.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 180 Life Sciences Corp. stocks are traded under the ticker ATNF.
180 Life Sciences Corp. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
ATNF stock is 13.63% volatile and has beta coefficient of 1.87. Check out the list of the most volatile stocks — is 180 Life Sciences Corp. there?
ATNF earnings for the last quarter are 19.00 USD per share, whereas the estimation was −49.40 USD resulting in a 138.46% surprise. The estimated earnings for the next quarter are −49.40 USD per share. See more details about 180 Life Sciences Corp. earnings.
Yes, you can track 180 Life Sciences Corp. financials in yearly and quarterly reports right on TradingView.
ATNF stock has fallen by 18.92% compared to the previous week, the month change is a 47.83% fall, over the last year 180 Life Sciences Corp. has showed a 92.36% decrease.
ATNF net income for the last quarter is ‪−1.23 M‬ USD, while the quarter before that showed ‪−10.27 M‬ USD of net income which accounts for 88.05% change. Track more 180 Life Sciences Corp. financial stats to get the full picture.
Today 180 Life Sciences Corp. has the market capitalization of ‪962.42 K‬, it has increased by 12.32% over the last week.
No, ATNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 180 Life Sciences Corp. stock right from TradingView charts — choose your broker and connect to your account.
ATNF reached its all-time high on Apr 12, 2021 with the price of 4957.21 USD, and its all-time low was 1.33 USD and was reached on Apr 16, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 4.00 employees. See our rating of the largest employees — is 180 Life Sciences Corp. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 180 Life Sciences Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 180 Life Sciences Corp. stock shows the sell signal. See more of 180 Life Sciences Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.